{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:21:42Z","timestamp":1763400102814,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.japh.2022.10.026","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T02:31:10Z","timestamp":1668220270000},"page":"633-637.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-term antibiotic prescribing in the community: 6 years of Australian national data"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2332-8186","authenticated-orcid":false,"given":"Aleece","family":"MacPhail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Korman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2928-1291","authenticated-orcid":false,"given":"Ian","family":"Woolley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6797-4307","authenticated-orcid":false,"given":"Jillian","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.japh.2022.10.026_bib1","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/jac\/dky174","article-title":"Life-long antimicrobial therapy: where is the evidence?","volume":"73","author":"Lau","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.japh.2022.10.026_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12941-017-0180-6","article-title":"Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network","volume":"16","author":"Lau","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.japh.2022.10.026_bib3","unstructured":"Australian government department of health pharmaceutical benefits scheme. Australian Statistics on Medicine 2011; 2011. https:\/\/www.pbs.gov.au\/info\/statistics\/asm\/asm-2011. Accessed October 30, 2022."},{"key":"10.1016\/j.japh.2022.10.026_bib6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1186\/s13104-015-1616-8","article-title":"The Australian pharmaceutical benefits scheme data collection: a practical guide for researchers","volume":"8","author":"Mellish","year":"2015","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.japh.2022.10.026_bib7","doi-asserted-by":"crossref","first-page":"e1202","DOI":"10.1093\/cid\/ciac277","article-title":"Reductions in antibiotic prescribing in Australia during the Severe Acute Respiratory Syndrome Coronavirus 2 pandemic: national prescribing data","volume":"75","author":"Skeggs","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.japh.2022.10.026_bib9","unstructured":"Australian Bureau of Statistics. Quarterly Population Estimates (ERP) by State\/Territory, Sex and Age; 2021. https:\/\/www.abs.gov.au\/statistics\/people\/population\/national-state-and-territory-population\/jun-2021. Accessed October 30, 2022."},{"issue":"10","key":"10.1016\/j.japh.2022.10.026_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2165\/11595050-000000000-00000","article-title":"Antimicrobial prescribing in nursing homes in Northern Ireland: results of two point-prevalence surveys","volume":"28","author":"McClean","year":"2011","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.japh.2022.10.026_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s15010-012-0331-9","article-title":"Antimicrobial prescribing in nursing homes in Finland: results of three point prevalence surveys","volume":"41","author":"Rummukainen","year":"2013","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.japh.2022.10.026_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ajic.2019.08.034","article-title":"Urinary tract infections in Australian aged care homes: antibiotic prescribing practices and concordance to national guidelines","volume":"48","author":"Dowson","year":"2020","journal-title":"Am J Infect Control"},{"issue":"1","key":"10.1016\/j.japh.2022.10.026_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jamda.2019.11.009","article-title":"Epidemiology of antibiotic use for urinary tract infection in nursing home residents","volume":"21","author":"Thompson","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"4","key":"10.1016\/j.japh.2022.10.026_bib14","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.arth.2019.11.026","article-title":"The role of long-term antibiotic suppression in the management of peri-prosthetic joint infections treated with debridement, antibiotics, and implant retention: a systematic review","volume":"35","author":"Malahias","year":"2020","journal-title":"J\u00a0Arthroplasty"},{"issue":"4","key":"10.1016\/j.japh.2022.10.026_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5694\/mja14.00249","article-title":"Are high coronary risk patients missing out on lipid-lowering drugs in Australia?","volume":"201","author":"Simons","year":"2014","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.japh.2022.10.026_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12889-018-6325-5","article-title":"HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme","volume":"19","author":"Dharan","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.japh.2022.10.026_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jclinepi.2018.04.015","article-title":"National characteristics and trends in antiretroviral treatment in Australia can be accurately estimated using a large clinical cohort","volume":"100","author":"Huang","year":"2018","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.japh.2022.10.026_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/jech-2013-202744","article-title":"Use of administrative medical databases in population-based research","volume":"68","author":"Gavrielov-Yusim","year":"2014","journal-title":"J\u00a0Epidemiol Community Health"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122003776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122003776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:52:07Z","timestamp":1761544327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319122003776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1544319122003776"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2022.10.026","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term antibiotic prescribing in the community: 6 years of Australian national data","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2022.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}